Shopping Cart
- Remove All
- Your shopping cart is currently empty
HDAC-IN-46 (compound 12c) is a potent inhibitor of HDAC, targeting HDAC1 (IC50: 0.21 μM) and HDAC6 (IC50: 0.021 μM). It upregulates p-p38, downregulates Bcl-xL and cyclin D1 in MDA-MB-231 cells, blocks the cell cycle in the G2 phase, and induces apoptosis, making it useful for triple negative breast cancer (TNBC) studies.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,140 | 8-10 weeks | |
50 mg | $2,785 | 8-10 weeks | |
100 mg | $3,520 | 8-10 weeks |
Description | HDAC-IN-46 (compound 12c) is a potent inhibitor of HDAC, targeting HDAC1 (IC50: 0.21 μM) and HDAC6 (IC50: 0.021 μM). It upregulates p-p38, downregulates Bcl-xL and cyclin D1 in MDA-MB-231 cells, blocks the cell cycle in the G2 phase, and induces apoptosis, making it useful for triple negative breast cancer (TNBC) studies. |
Molecular Weight | 438.53 |
Formula | C22H30N8O2 |
Cas No. | 2562386-85-8 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.